Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT07943598
PHASE2

A Global Phase 2 Extension Study of Brogidirsen in Boys With Duchenne Muscular Dystrophy

Sponsor: NS Pharma, Inc.

View on ClinicalTrials.gov

Summary

This Phase 2, open-label, multi-center extension study will be conducted in boys with DMD who completed the 24-week Treatment Period of Study NS-089/NCNP-02-201. Brogidirsen will be administered by IV infusion once weekly for up to 120 weeks (up to a total of 144 weeks of treatment, including weekly dosing from Part 2 of Study NS-089/NCNP-02-201) or until brogidirsen is commercially available, whichever is earlier.

Official title: A Phase 2 Open-Label Extension Study to Assess the Safety and Efficacy of Brogidirsen in Boys With Duchenne Muscular Dystrophy (DMD)

Key Details

Gender

MALE

Age Range

Any - Any

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2026-12-16

Completion Date

2029-09-03

Last Updated

2026-11-17

Healthy Volunteers

No

Interventions

DRUG

Brogidirsen

Brogidirsen will be administered for up to 120 weeks (up to a total of 144 weeks of treatment, including weekly dosing from Part 2 of Study NS-089/NCNP-02-201) or until Brogidirsen is commercially available, whichever is earlier.

Locations (17)

Children's Hospital Colorado

Aurora, Colorado, United States

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States

Virginia Commonwealth University Health System

Richmond, Virginia, United States

Queensland Children's Hospital

South Brisbane, Queensland, Australia

British Columbia Children's Hospital

Vancouver, British Columbia, Canada

London Health Sciences Centre

London, Ontario, Canada

Fukui Prefectural Hospital

Fukui-shi, Fukui, Japan

NHO Nagara Medical Center

Nagara, Gifu-shi, Gifu, Japan

NHO Osaka Toneyama Medical Center

Toyonaka, Osaka, Japan

Shiga General Hospital

Moriyama-shi, Shiga, Japan

National Center of Neurology and Psychiatry

Kodaira, Tokyo, Japan

Starship Children's Hospital

Auckland, New Zealand

Pusan National University Yangsan Hospital

Yangsan, Gyeongsangnam, South Korea

Seoul National University Hospital

Seoul, South Korea

Ankara Bilkent City Hospital

Ankara, Turkey, Turkey (Türkiye)

Yeditepe University Kosuyolu Hospital

Istanbul, Turkey, Turkey (Türkiye)

S.B.U. Dr. Behcet uz Pediatric Diseases and Surgery Training and Research Hospital

Izmir, Turkey, Turkey (Türkiye)